Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06560476 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH

Study acronym: APEX
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status changed: Recruiting → Active, Not Recruiting
    • Study sites: 9 to 8
    v8
  2. Site details revised at 1 of 9 sitesv7
  3. Study sites: 8 to 9v6
  4. Study sites: 6 to 8v5
  5. Study sites: 4 to 6v4
Show 2 earlier versionsHide 2 earlier versions
  1. Study sites: 3 to 4v3
  2. Trial status: Active, Not Recruiting to Recruiting
    • Study sites: 1 to 3
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Urotronic Inc.
6 trials monitored
See 1 trial at risk
APEX is a prospective multi-site registry of real-world experience with the Optilume™ BPH Catheter System for treatment of men experiencing symptomatic BPH.
Trial Details
NCT Number NCT06560476
Lead Sponsor Urotronic Inc.
Conditions
(from sponsor)		 Benign Prostatic Hyperplasia
Related terms Prostatic Hyperplasia
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov